Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Placental-Based Skin Substitutes and Standard of Care Versus SOC Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers

NCT06449638 is registered in ClinicalTrials.gov with StimLabs as lead sponsor.

NCT NCT06449638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Placental-Based Skin Substitutes and Standard of Care Versus SOC Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Lead sponsor
StimLabs
Phase
Not applicable
Overall status
Recruiting
Start date
July 16, 2024
Completion date
December 31, 2026
Enrollment
272 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, diabetic foot ulcer (dfu), foot ulcer, ulcer foot